Yahoo
LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV capsid across the blood-brain barrier (BBB). The article, titled “Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-b
Finnhub
Voyager Therapeutics, Inc. announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase to transport a novel AAV capsid across the blood-brain barrier . The...
Yahoo
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -51.43% and 66.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
– Tau silencing gene therapy VY1706 to be featured in oral presentation at ASGCT 2025; has shown up to 73% knockdown of tau mRNA in the CNS in NHPs following a single IV dose of 1.3e13 vg/kg – – Recent Voyager data on VY7523 and VY1706 presented at AD/PD™ 2025 continue to support tau as next critical target in Alzheimer’s disease – LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurol
Finnhub
LEXINGTON, Mass. — LEXINGTON, Mass. — Voyager Therapeutics Inc. on Tuesday reported a loss of $31 million in its first quarter. On a per-share basis, the Lexington, Massachusetts-based...
Yahoo
- Oral presentation on tau silencing gene therapy VY1706, which has previously shown up to 73% knockdown of tau mRNA in NHPs in the CNS following a single IV dose of 1.3e13 vg/kg - - Featured data also include anti-amyloid gene therapy for Alzheimer’s disease, as well as multiple presentations on Voyager’s continued enhancements to its highly BBB penetrant novel capsids - LEXINGTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedic
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 56.24% | $4.85B | 0.35% |
IWC | 54.99% | $766.88M | 0.6% |
IBB | 53.90% | $5.22B | 0.45% |
GNOM | 53.73% | $40.65M | 0.5% |
IWO | 53.02% | $11.36B | 0.24% |
ARKG | 52.37% | $944.78M | 0.75% |
VTWO | 51.53% | $12.07B | 0.07% |
IWM | 51.49% | $63.95B | 0.19% |
KJAN | 50.65% | $305.13M | 0.79% |
SCHA | 50.21% | $16.91B | 0.04% |
GSSC | 50.17% | $538.65M | 0.2% |
CPRJ | 49.27% | $48.43M | 0.69% |
ESML | 49.21% | $1.81B | 0.17% |
NUSC | 49.13% | $1.14B | 0.31% |
ISCG | 49.10% | $645.00M | 0.06% |
KOMP | 49.02% | $2.20B | 0.2% |
PBE | 48.98% | $214.12M | 0.58% |
IWN | 48.72% | $11.10B | 0.24% |
SMMD | 48.63% | $1.46B | 0.15% |
PRFZ | 48.61% | $2.33B | 0.34% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | <0.01% | $23.29B | -11.36% | 1.23% |
T | -0.08% | $196.66B | +57.98% | 4.07% |
EVRG | 0.20% | $15.12B | +18.08% | 3.98% |
JNJ | 0.29% | $360.54B | -3.03% | 3.32% |
EDU | -0.32% | $7.99B | -41.11% | 0.00% |
PG | -0.32% | $380.78B | -3.25% | 2.51% |
SAND | 0.36% | $2.39B | +43.23% | 0.72% |
CORT | -0.49% | $7.78B | +166.38% | 0.00% |
MSIF | -0.64% | $715.25M | +28.42% | 7.05% |
DGX | 0.68% | $19.69B | +23.86% | 1.73% |
COR | 0.74% | $55.43B | +28.90% | 0.56% |
PULM | -0.80% | $23.82M | +239.64% | 0.00% |
CPSH | 0.86% | $27.45M | +8.62% | 0.00% |
KDP | -1.11% | $45.55B | -1.76% | 2.70% |
AU | 1.11% | $20.37B | +64.23% | 2.29% |
PHYS.U | 1.21% | - | - | 0.00% |
NTZ | 1.30% | $38.55M | -34.46% | 0.00% |
AQB | -1.32% | $2.96M | -61.58% | 0.00% |
CYD | 1.32% | $643.06M | +106.88% | 2.24% |
PRT | -1.34% | $46.96M | +0.80% | 11.43% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -36.61% | $361.41M | 1.43% |
VIXY | -32.46% | $109.64M | 0.85% |
TAIL | -31.00% | $140.49M | 0.59% |
IVOL | -21.11% | $353.94M | 1.02% |
SPTS | -15.92% | $5.76B | 0.03% |
IBTG | -14.49% | $1.88B | 0.07% |
ULST | -14.11% | $637.77M | 0.2% |
STPZ | -13.93% | $446.46M | 0.2% |
UTWO | -13.68% | $387.71M | 0.15% |
XONE | -13.36% | $603.24M | 0.03% |
VTIP | -12.46% | $14.78B | 0.03% |
IBTH | -10.61% | $1.53B | 0.07% |
FXY | -10.61% | $838.61M | 0.4% |
LDUR | -10.18% | $849.09M | 0.5% |
VGSH | -10.12% | $22.38B | 0.03% |
XHLF | -10.04% | $1.46B | 0.03% |
SCHO | -10.04% | $10.87B | 0.03% |
IBTI | -9.40% | $995.39M | 0.07% |
STIP | -9.13% | $11.88B | 0.03% |
UDN | -9.09% | $137.74M | 0.78% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HIHO | -17.05% | $8.25M | -10.29% | 3.73% |
PM | -16.41% | $263.27B | +68.03% | 3.17% |
CBOE | -14.80% | $22.95B | +20.67% | 1.12% |
KO | -11.82% | $308.23B | +13.09% | 2.75% |
FMTO | -10.00% | $45.74M | -99.96% | 0.00% |
EXC | -9.23% | $43.84B | +12.45% | 3.59% |
VHC | -9.11% | $34.69M | +74.89% | 0.00% |
ED | -9.02% | $36.75B | +5.26% | 3.28% |
TIMB | -7.71% | $8.38B | +3.30% | 2.99% |
CME | -7.41% | $98.74B | +28.80% | 3.84% |
ZCMD | -7.29% | $32.45M | -11.38% | 0.00% |
LITB | -7.00% | $21.28M | -72.45% | 0.00% |
MDLZ | -6.83% | $84.34B | -9.43% | 2.85% |
MO | -6.74% | $97.80B | +26.35% | 6.94% |
CL | -6.63% | $72.64B | -5.18% | 2.25% |
CIG.C | -6.62% | $2.45B | +9.77% | 0.00% |
DUK | -6.43% | $90.12B | +12.74% | 3.61% |
AEP | -5.90% | $54.28B | +9.80% | 3.61% |
AMT | -5.56% | $99.10B | +8.59% | 3.09% |
K | -4.35% | $28.49B | +32.17% | 2.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMCO | 48.66% | $502.72M | -60.61% | 1.58% |
RGNX | 48.48% | $433.39M | -46.03% | 0.00% |
MEDP | 48.23% | $8.52B | -24.63% | 0.00% |
IMNM | 47.60% | $696.10M | -44.44% | 0.00% |
IPGP | 47.07% | $2.78B | -26.19% | 0.00% |
RCKT | 46.91% | $724.54M | -71.26% | 0.00% |
XNCR | 46.70% | $583.60M | -63.49% | 0.00% |
KYMR | 46.03% | $1.95B | -15.67% | 0.00% |
IOSP | 46.03% | $2.20B | -32.27% | 1.77% |
SLAB | 46.00% | $4.34B | +2.29% | 0.00% |
XENE | 45.17% | $2.27B | -26.70% | 0.00% |
EYPT | 45.14% | $393.60M | -54.31% | 0.00% |
KN | 45.04% | $1.48B | -2.96% | 0.00% |
NTLA | 44.87% | $836.43M | -69.14% | 0.00% |
DNLI | 44.80% | $2.06B | -30.04% | 0.00% |
NOVT | 44.66% | $4.66B | -21.25% | 0.00% |
BDC | 44.60% | $4.42B | +19.84% | 0.18% |
RXRX | 44.47% | $1.73B | -55.31% | 0.00% |
BCO | 44.23% | $3.72B | -9.19% | 0.82% |
ACLX | 44.20% | $3.22B | +10.72% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBO | -0.03% | $182.54M | 0.77% |
TIP | 0.03% | $13.74B | 0.18% |
IGOV | 0.07% | $994.85M | 0.35% |
COMT | -0.07% | $606.15M | 0.48% |
SPMB | -0.08% | $5.82B | 0.04% |
KMLM | 0.10% | $188.32M | 0.9% |
CGCB | -0.12% | $2.19B | 0.27% |
PDBC | 0.14% | $4.43B | 0.59% |
JUCY | -0.17% | $297.77M | 0.6% |
GOVI | -0.25% | $870.08M | 0.15% |
IBND | 0.33% | $291.26M | 0.5% |
HTAB | 0.33% | $405.24M | 0.39% |
UCON | -0.38% | $3.06B | 0.85% |
MMIN | 0.39% | $469.53M | 0.3% |
TBLL | 0.39% | $2.46B | 0.08% |
JPST | 0.49% | $30.82B | 0.18% |
TAXF | -0.52% | $500.81M | 0.29% |
FIXD | 0.57% | $3.54B | 0.65% |
FMHI | -0.58% | $757.44M | 0.7% |
SPIP | 0.62% | $984.63M | 0.12% |
Current Value
$3.281 Year Return
Current Value
$3.281 Year Return